Copyright Reports & Markets. All rights reserved.

Global Alcohol Addiction Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Alcohol Addiction Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Alcohol Addiction Therapeutics
      • 1.2 Alcohol Addiction Therapeutics Segment by Type
        • 1.2.1 Global Alcohol Addiction Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 CM-1212
        • 1.2.3 CTDP-002
        • 1.2.4 A-705253
        • 1.2.5 ABT-436
        • 1.2.6 ADX-71441
        • 1.2.7 Others
      • 1.3 Alcohol Addiction Therapeutics Segment by Application
        • 1.3.1 Alcohol Addiction Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Alcohol Addiction Therapeutics Market by Region
        • 1.3.1 Global Alcohol Addiction Therapeutics Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Alcohol Addiction Therapeutics Market Size
        • 1.4.1 Global Alcohol Addiction Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Alcohol Addiction Therapeutics Production (2014-2025)

      2 Global Alcohol Addiction Therapeutics Market Competition by Manufacturers

      • 2.1 Global Alcohol Addiction Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Alcohol Addiction Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Alcohol Addiction Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Alcohol Addiction Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Alcohol Addiction Therapeutics Market Concentration Rate
        • 2.5.2 Alcohol Addiction Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Alcohol Addiction Therapeutics Production Market Share by Regions

      • 3.1 Global Alcohol Addiction Therapeutics Production Market Share by Regions
      • 3.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Alcohol Addiction Therapeutics Production
        • 3.4.1 North America Alcohol Addiction Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Alcohol Addiction Therapeutics Production
        • 3.5.1 Europe Alcohol Addiction Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Alcohol Addiction Therapeutics Production (2014-2019)
        • 3.6.1 China Alcohol Addiction Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Alcohol Addiction Therapeutics Production (2014-2019)
        • 3.7.1 Japan Alcohol Addiction Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Alcohol Addiction Therapeutics Consumption by Regions

      • 4.1 Global Alcohol Addiction Therapeutics Consumption by Regions
      • 4.2 North America Alcohol Addiction Therapeutics Consumption (2014-2019)
      • 4.3 Europe Alcohol Addiction Therapeutics Consumption (2014-2019)
      • 4.4 China Alcohol Addiction Therapeutics Consumption (2014-2019)
      • 4.5 Japan Alcohol Addiction Therapeutics Consumption (2014-2019)

      5 Global Alcohol Addiction Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Alcohol Addiction Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Alcohol Addiction Therapeutics Price by Type (2014-2019)
      • 5.4 Global Alcohol Addiction Therapeutics Production Growth by Type (2014-2019)

      6 Global Alcohol Addiction Therapeutics Market Analysis by Applications

      • 6.1 Global Alcohol Addiction Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Alcohol Addiction Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Alcohol Addiction Therapeutics Business

      • 7.1 AstraZeneca Plc
        • 7.1.1 AstraZeneca Plc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.1.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 BioCorRx Inc
        • 7.2.1 BioCorRx Inc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.2.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Bionex Pharmaceuticals LLC
        • 7.3.1 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.3.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Cerecor Inc
        • 7.4.1 Cerecor Inc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.4.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Cerecor Inc Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Chronos Therapeutics Ltd
        • 7.5.1 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.5.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Corcept Therapeutics Inc
        • 7.6.1 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.6.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Curemark LLC
        • 7.7.1 Curemark LLC Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.7.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Curemark LLC Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Eli Lilly and Company
        • 7.8.1 Eli Lilly and Company Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.8.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Ethypharm SA
        • 7.9.1 Ethypharm SA Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.9.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.9.3 Ethypharm SA Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 H. Lundbeck A/S
        • 7.10.1 H. Lundbeck A/S Alcohol Addiction Therapeutics Production Sites and Area Served
        • 7.10.2 Alcohol Addiction Therapeutics Product Introduction, Application and Specification
        • 7.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Heptares Therapeutics Ltd
      • 7.12 Indivior Plc
      • 7.13 Kinnov Therapeutics SAS
      • 7.14 Kyorin Pharmaceutical Co Ltd
      • 7.15 Lohocla Research Corp
      • 7.16 Montisera Ltd
      • 7.17 Omeros Corp
      • 7.18 Opiant Pharmaceuticals Inc

      8 Alcohol Addiction Therapeutics Manufacturing Cost Analysis

      • 8.1 Alcohol Addiction Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Alcohol Addiction Therapeutics
      • 8.4 Alcohol Addiction Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Alcohol Addiction Therapeutics Distributors List
      • 9.3 Alcohol Addiction Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Alcohol Addiction Therapeutics Market Forecast

      • 11.1 Global Alcohol Addiction Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Alcohol Addiction Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Alcohol Addiction Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Alcohol Addiction Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Alcohol Addiction Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Alcohol Addiction Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Alcohol Addiction Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Alcohol Addiction Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Alcohol Addiction Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Alcohol Addiction Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Alcohol Addiction Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Alcohol Addiction Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Alcohol Addiction Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Alcohol Addiction Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Alcohol Addiction Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Alcohol Addiction Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Alcohol Addiction Therapeutics market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Alcohol Addiction Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alcohol Addiction Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AstraZeneca Plc
        BioCorRx Inc
        Bionex Pharmaceuticals LLC
        Cerecor Inc
        Chronos Therapeutics Ltd
        Corcept Therapeutics Inc
        Curemark LLC
        Eli Lilly and Company
        Ethypharm SA
        H. Lundbeck A/S
        Heptares Therapeutics Ltd
        Indivior Plc
        Kinnov Therapeutics SAS
        Kyorin Pharmaceutical Co Ltd
        Lohocla Research Corp
        Montisera Ltd
        Omeros Corp
        Opiant Pharmaceuticals Inc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        CM-1212
        CTDP-002
        A-705253
        ABT-436
        ADX-71441
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now